Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Traditional foods and 25(OH)D concentrations in a subarctic First Nations community.

Mansuri S, Badawi A, Kayaniyil S, Cole DE, Harris SB, Mamakeesick M, Wolever T, Gittelsohn J, Maguire JL, Connelly PW, Zinman B, Hanley AJ.

Int J Circumpolar Health. 2016 Jan;75(1):31956. doi: 10.3402/ijch.v75.31956.

2.

Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.

Harris SB, Kocsis G, Prager R, Ridge T, Chandarana K, Halladin N, Jabbour S.

Diabetes Obes Metab. 2017 Jun;19(6):858-865. doi: 10.1111/dom.12892. Epub 2017 Mar 3.

3.

Developing community-driven quality improvement initiatives to enhance chronic disease care in Indigenous communities in Canada: the FORGE AHEAD program protocol.

Naqshbandi Hayward M, Paquette-Warren J, Harris SB; FORGE AHEAD Program Team.

Health Res Policy Syst. 2016 Jul 26;14(1):55. doi: 10.1186/s12961-016-0127-y.

4.

Case study of evaluations that go beyond clinical outcomes to assess quality improvement diabetes programmes using the Diabetes Evaluation Framework for Innovative National Evaluations (DEFINE).

Paquette-Warren J, Harris SB, Naqshbandi Hayward M, Tompkins JW.

J Eval Clin Pract. 2016 Oct;22(5):644-52. doi: 10.1111/jep.12510. Epub 2016 Jan 25.

5.

Sandy lake health and diabetes project: a community-based intervention targeting type 2 diabetes and its risk factors in a first nations community.

Kakekagumick KE, Naqshbandi Hayward M, Harris SB, Saksvig B, Gittelsohn J, Manokeesic G, Goodman S, Hanley AJ.

Front Endocrinol (Lausanne). 2013 Nov 12;4:170. doi: 10.3389/fendo.2013.00170. eCollection 2013.

6.

Short leg length, a marker of early childhood deprivation, is associated with metabolic disorders underlying type 2 diabetes: the PROMISE cohort study.

Johnston LW, Harris SB, Retnakaran R, Gerstein HC, Zinman B, Hamilton J, Hanley AJ.

Diabetes Care. 2013 Nov;36(11):3599-606. doi: 10.2337/dc13-0254. Epub 2013 Oct 2.

7.

Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective.

Harris SB, Khunti K, Landin-Olsson M, Galbo-Jørgensen CB, Bøgelund M, Chubb B, Gundgaard J, Evans M.

Patient Prefer Adherence. 2013 Sep 16;7:925-36. doi: 10.2147/PPA.S46805. eCollection 2013.

8.

Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial.

Harris SB, Gerstein HC, Yale JF, Berard L, Stewart J, Webster-Bogaert S, Tompkins JW.

BMC Health Serv Res. 2013 Feb 21;13:71. doi: 10.1186/1472-6963-13-71.

9.
10.

Managing cardiometabolic risk in primary care: summary of the 2011 consensus statement.

Chatterjee A, Harris SB, Leiter LA, Fitchett DH, Teoh H, Bhattacharyya OK; Cardiometabolic Risk Working Group (Canadian).

Can Fam Physician. 2012 Apr;58(4):389-93, e196-201. Review. English, French. No abstract available.

11.

Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of Indigenous cohorts with diabetes in Australia and Canada.

Maple-Brown LJ, Cunningham J, Zinman B, Mamakeesick M, Harris SB, Connelly PW, Shaw J, O'Dea K, Hanley AJ.

Cardiovasc Diabetol. 2012 Mar 28;11:30. doi: 10.1186/1475-2840-11-30.

12.

Challenges to the provision of diabetes care in first nations communities: results from a national survey of healthcare providers in Canada.

Bhattacharyya OK, Rasooly IR, Naqshbandi M, Estey EA, Esler J, Toth E, Macaulay AC, Harris SB.

BMC Health Serv Res. 2011 Oct 21;11:283. doi: 10.1186/1472-6963-11-283.

13.

Hypertension in people with type 2 diabetes: Update on pharmacologic management.

Campbell NR, Gilbert RE, Leiter LA, Larochelle P, Tobe S, Chockalingam A, Ward R, Morris D, Tsuyuki RT, Harris SB.

Can Fam Physician. 2011 Sep;57(9):997-1002, e347-53. Review. English, French. Erratum in: Can Fam Physician. 2011 Nov;57(11):1255.

14.

Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study.

Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, Perkins BA, Zinman B, Hanley AJ.

Diabetes. 2011 Nov;60(11):2947-53. doi: 10.2337/db11-0465. Epub 2011 Sep 12.

15.
17.

HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study.

Ley SH, Hegele RA, Harris SB, Mamakeesick M, Cao H, Connelly PW, Gittelsohn J, Retnakaran R, Zinman B, Hanley AJ.

BMC Med Genet. 2011 Jan 5;12:1. doi: 10.1186/1471-2350-12-1.

18.

Investigating concordance in diabetes diagnosis between primary care charts (electronic medical records) and health administrative data: a retrospective cohort study.

Harris SB, Glazier RH, Tompkins JW, Wilton AS, Chevendra V, Stewart MA, Thind A.

BMC Health Serv Res. 2010 Dec 23;10:347. doi: 10.1186/1472-6963-10-347.

19.

Clinical inertia in patients with T2DM requiring insulin in family practice.

Harris SB, Kapor J, Lank CN, Willan AR, Houston T.

Can Fam Physician. 2010 Dec;56(12):e418-24.

20.

Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI).

Teoh H, Braga MF, Casanova A, Drouin D, Goodman SG, Harris SB, Langer A, Tan MK, Ur E, Yan AT, Zinman B, Leiter LA; T2DM QUERI Investigators.

Diabetes Care. 2010 Dec;33(12):2558-60. doi: 10.2337/dc10-0440. Epub 2010 Sep 7.

Supplemental Content

Loading ...
Support Center